PPLPHARMA.NS · Piramal Pharma Limited
India · RS rating 72 · As of 2026-10-14
| Price | 193.94 INR |
|---|---|
| 1-day change | -1.1% |
| RS rating (overall / 1M / 3M / 12M) | 72 / 26 / 80 / 63 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 37 / 47 / 38 |
| Industry group (rank) | Pharma (32) |
| EPS growth Q/Q | -642.9% |
| Sales growth Q/Q | -17.5% |
| Distance from 52-week high | +14.4% |
| Market cap (USD) | $2.7B |